Weight Loss Stocks Could Become Alzheimer's Drugs Stocks. Here's Why That's Bullish for Novo Nordisk
12/8 12:30
As if billions of dollars in sales of weight loss drugs weren't enough, Novo Nordisk (NYSE: NVO) and its peers developing those medicines have a new opportunity that just might pad their wallets further. There's now reason to believe that the nascent market for Alzheimer's diseas...